Fernie, GordonCurrie, JamesPerrin, Jennifer S.Stewart, Caroline A.Anderson, VirginicaBennett, Daniel M.Hay, StevenReid, Ian C.2017-03-022017-03-022017-06Fernie, G, Currie, J, Perrin, J S, Stewart, C A, Anderson, V, Bennett, D M, Hay, S & Reid, I C 2017, 'Ketamine as the anaesthetic for electroconvulsive therapy : the KANECT randomised controlled trial', British Journal of Psychiatry, vol. 210, no. 3, pp. 1-7. https://doi.org/10.1192/bjp.bp.116.1891340007-1250ORCID: /0000-0001-7384-9361/work/169078733http://hdl.handle.net/2164/8278C.AS. reports grants from Vifor Pharma, outside the submitted work. I.C.R. (deceased) declared personal fees from AstraZeneca, Sanofi Aventis and Sunovion, and non-financial support from Lundbeck, between 2009 and 2014 and all outside the submitted work. Volume 212, Issue 5 May 2018 , p. 323 Ketamine as the anaesthetic for electroconvulsive therapy: the KANECT randomised controlled trial – CORRIGENDUM Gordon Fernie, James Currie, Jennifer S. Perrin, Caroline A. Stewart... https://doi.org/10.1192/bjp.2018.76 Published online: 06 April 2018 Summary: This notice describes a correction to the above mentioned paper.7619591engR MedicineRJournal article10.1192/bjp.bp.116.189134http://10.1192/bjp.2018.762103